The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of ...

Gen Z, with their digital fluency and preference for hands-on learning, is already reshaping workforce expectations. To meet ...